CAR T-cell therapy: is it prime time in myeloma? Read more about CAR T-cell therapy: is it prime time in myeloma?
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Read more about Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Read more about Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1. Read more about Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.
Related and unrelated donor transplantation for β-thalassemia major: results of an international survey. Read more about Related and unrelated donor transplantation for β-thalassemia major: results of an international survey.
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Read more about Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.
Depletion of murine fetal hematopoietic stem cells with c-Kit receptor and CD47 blockade improves neonatal engraftment. Read more about Depletion of murine fetal hematopoietic stem cells with c-Kit receptor and CD47 blockade improves neonatal engraftment.
IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. Read more about IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice.
Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia. Read more about Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.
Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation. Read more about Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation.
